We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+0.28%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$360B
AUM Growth
-$5.05B
Cap. Flow
-$2.61B
Cap. Flow %
-0.72%
Top 10 Hldgs %
13.81%
Holding
6,930
New
170
Increased
3,227
Reduced
2,806
Closed
155

Sector Composition

Rank Sector Weight
1 Technology 11.4%
2 Financials 10.07%
3 Consumer Discretionary 8.39%
4 Healthcare 7.69%
5 Communication Services 6.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTRX icon
4076
Matrix Service
MTRX
$343M
$1.66M ﹤0.01%
120,888
+59,267
+96% +$975K
FT
4077
Franklin Universal Trust
FT
$199M
$1.65M ﹤0.01%
244,486
+39,726
+19% +$274K
FTAG icon
4078
First Trust Exchange-Traded Fund II First Trust Indxx Global Agriculture ETF
FTAG
$14.4M
$1.65M ﹤0.01%
62,119
+4,201
+7% +$118K
MTBL
4079
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$1.65M ﹤0.01%
655,197
+325,304
+99% +$979K
AGEN
4080
Agenus
AGEN
$346M
$1.65M ﹤0.01%
17,854
+3,354
+23% +$298K
ICPT
4081
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.65M ﹤0.01%
26,809
-397,210
-94% -$23.9M
DGII icon
4082
Digi International
DGII
$2.72B
$1.65M ﹤0.01%
159,986
-4,873
-3% -$50.6K
GLDD
4083
DELISTED
Great Lakes Dredge & Dock
GLDD
$1.65M ﹤0.01%
357,833
-73,847
-17% -$350K
VBTX
4084
DELISTED
Veritex Holdings
VBTX
$1.65M ﹤0.01%
59,483
+20,946
+54% +$592K
FBC
4085
DELISTED
Flagstar Bancorp, Inc. New
FBC
$1.65M ﹤0.01%
46,511
-1,588
-3% -$58.2K
AVID
4086
DELISTED
Avid Technology Inc
AVID
$1.64M ﹤0.01%
362,104
-108,940
-23% -$553K
ORIT
4087
DELISTED
Oritani Financial Corp. New
ORIT
$1.64M ﹤0.01%
107,064
+1,670
+2% +$26.9K
SRF
4088
DELISTED
THE CUSHING ROYALTY & INCOME FUND
SRF
$1.64M ﹤0.01%
188,271
+37,736
+25% +$346K
NC icon
4089
NACCO Industries
NC
$360M
$1.64M ﹤0.01%
49,930
+11,575
+30% +$466K
NWLI
4090
DELISTED
National Western Life Group, Inc. Class A
NWLI
$1.64M ﹤0.01%
5,376
-1,677
-24% -$534K
URTH icon
4091
iShares MSCI World ETF
URTH
$8.22B
$1.64M ﹤0.01%
18,791
+5,451
+41% +$488K
WHD icon
4092
Cactus
WHD
$5.39B
$1.64M ﹤0.01%
+60,722
New +$1.53M
BHBK
4093
DELISTED
Blue Hills Bancorp, Inc.
BHBK
$1.64M ﹤0.01%
78,490
+25,079
+47% +$507K
CAF
4094
Morgan Stanley China A Share Fund
CAF
$319M
$1.64M ﹤0.01%
65,666
+11,617
+21% +$295K
PFO
4095
Flaherty & Crumrine Preferred and Income Opportunity Fund
PFO
$120M
$1.64M ﹤0.01%
150,544
+5,240
+4% +$58.5K
REV
4096
DELISTED
Revlon, Inc.
REV
$1.64M ﹤0.01%
79,352
+13,036
+20% +$280K
BXC icon
4097
BlueLinx
BXC
$502M
$1.63M ﹤0.01%
50,166
+46,998
+1,484% +$873K
NVGS icon
4098
Navigator Holdings
NVGS
$1.32B
$1.63M ﹤0.01%
138,533
+158
+0.1% +$1.82K
TRIL
4099
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.63M ﹤0.01%
225,895
+65,040
+40% +$493K
FPRX
4100
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.63M ﹤0.01%
94,705
-256,961
-73% -$5.01M

Similar funds

Morgan Stanley's Q1 2018 Portfolio in Review

As of Q1 2018, Morgan Stanley held 6,930 positions worth $360B, down 1.4% from $365B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Trading was light in Q1 2018: portfolio turnover was 4.7%. Morgan Stanley opened 170 new positions and exited 155, leaving the 6,930-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q1 2018 buy was Nutrien: 1,554,481 shares worth $73.5M.
  • Morgan Stanley added most to iShares Russell 2000 ETF in Q1 2018, an estimated $1.27B increase.
  • Morgan Stanley's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.33B.
  • Morgan Stanley fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $86M.
  • Morgan Stanley's ten largest holdings make up 14% of its $360B portfolio in Q1 2018.
  • Morgan Stanley opened 170 new positions and closed 155 in Q1 2018.
  • Morgan Stanley's portfolio value fell 1.4% quarter-over-quarter to $360B.

Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.